Rapport Therapeutics, Inc. Common Stock
USD42.56
+2.35 (+5.84%)
CEO
Abraham N. Ceesay
IPO Date
2024-06-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$39.96
Prev. Close
$40.21
Day Low
$39.93
Day High
$43.29
52W Low
$13.62
52W High
$44.28
Market Cap
$1.55B
Volume
0.26M
| 2,729 |
| $40.57 |
| 1 Jul 2026 | Gault Cheryl | Chief Operating Officer | S-Sale | Disposed | 1,900 | $40.09 |
| 1 Jul 2026 | Gault Cheryl | Chief Operating Officer | S-Sale | Disposed | 3,792 | $41.39 |
| 1 Jul 2026 | Gault Cheryl | Chief Operating Officer | S-Sale | Disposed | 3,308 | $42.17 |
| 1 Jul 2026 | Gault Cheryl | Chief Operating Officer | S-Sale | Disposed | 1,000 | $43.15 |
| 1 Jul 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | S-Sale | Disposed | 7,344 | $39.77 |
| 1 Jul 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | S-Sale | Disposed | 876 | $40.34 |
| 10 Jun 2026 | MARAGANORE JOHN | director | A-Award | Acquired | 15,200 | $35.21 |
| 10 Jun 2026 | PEREZ ROBERT J | director | A-Award | Acquired | 15,200 | $35.21 |